Russell Investments Group’s Minerva Neurosciences NERV Stock Holding History

Russell Investments Group’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.1K	Buy	+2,722	New	+$14.8K	﹤0.01%	3862
2024 Q4	–	Sell	-1,175	Closed	-$3.14K	–	3762
2024 Q3	$3.14K	Hold	1,175	–	–	﹤0.01%	3307
2024 Q2	$3.75K	Hold	1,175	–	–	﹤0.01%	3274
2024 Q1	$3.03K	Hold	1,175	–	–	﹤0.01%	3017
2023 Q4	$7.23K	Hold	1,175	–	–	﹤0.01%	2863
2023 Q3	$8.11K	Hold	1,175	–	–	﹤0.01%	3054
2023 Q2	$10.7K	Hold	1,175	–	–	﹤0.01%	2953
2023 Q1	$1.88K	Hold	1,175	–	–	﹤0.01%	3016
2022 Q4	$1.87K	Hold	1,175	–	–	﹤0.01%	2880
2022 Q3	$10K	Hold	1,175	–	–	﹤0.01%	2865
2022 Q2	$3K	Hold	1,175	–	–	﹤0.01%	2865
2022 Q1	$7K	Hold	1,175	–	–	﹤0.01%	2722
2021 Q4	$7K	Sell	1,175 -10,394	-90%	-$97.9K	﹤0.01%	2980
2021 Q3	$160K	Sell	11,569 -267	-2%	-$4.02K	﹤0.01%	2812
2021 Q2	$218K	Sell	11,836 -970	-8%	-$20.9K	﹤0.01%	2881
2021 Q1	$297K	Sell	12,806 -13,947	-52%	-$348K	﹤0.01%	2718
2020 Q4	$499K	Sell	26,753 -2,739	-9%	-$69K	﹤0.01%	2430
2020 Q3	$749K	Buy	29,492 +4,069	+16%	+$110K	﹤0.01%	2203
2020 Q2	$732K	Buy	25,423 +6,130	+32%	+$360K	﹤0.01%	2210
2020 Q1	$930K	Buy	19,293 +14,632	+314%	+$883K	﹤0.01%	1871
2019 Q4	$264K	Buy	+4,661	New	+$206K	﹤0.01%	2621
2019 Q3	–	Sell	-2,653	Closed	-$119K	–	3074
2019 Q2	$119K	Buy	2,653 +1,936	+270%	+$96.9K	﹤0.01%	2613
2019 Q1	$45K	Buy	717 +189	+36%	+$11.4K	﹤0.01%	2808
2018 Q4	$28K	Sell	528 -18,544	-97%	-$1.36M	﹤0.01%	2844
2018 Q3	$1.91M	Buy	19,072 +5,043	+36%	+$379K	﹤0.01%	1782
2018 Q2	$925K	Buy	+14,029	New	+$852K	﹤0.01%	2157
2017 Q4	–	Sell	-1,834	Closed	-$112K	–	2991
2017 Q3	$112K	Sell	1,834 -140	-7%	-$8.03K	﹤0.01%	2760
2017 Q2	$140K	Buy	1,974 +697	+55%	+$45.1K	﹤0.01%	2762
2017 Q1	$83K	Sell	1,277 -5,219	-80%	-$405K	﹤0.01%	2841
2016 Q4	$619K	Buy	+6,496	New	+$663K	﹤0.01%	2389

Other funds holding NERV

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Russell Investments Group's NERV Position: Q2 2026 in Review

Russell Investments Group opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 2,722 shares worth $15.1K. The stake represents ﹤0.01% of the portfolio and ranks #3862 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in NERV as recently as Q3 2024.

Russell Investments Group first reported a position in NERV in Q4 2016 and has held it in 30 quarters since. The position peaked at $1.91M in Q3 2018. 12 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

Russell Investments Group held 2,722 shares of Minerva Neurosciences worth $15.1K as of Q2 2026.
Minerva Neurosciences was a new Russell Investments Group position in Q2 2026.
Minerva Neurosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3862 holding.
Russell Investments Group first reported a position in Minerva Neurosciences in Q4 2016 and has held it in 30 quarters since.
Russell Investments Group's Minerva Neurosciences position peaked at $1.91M in Q3 2018.
12 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.